logo
15:58 May 29

Ambalal Sarabhai Enterprises Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
35.29
+0.77 (+2.23%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Ambalal Sarabhai Enterprises Ltd. Financials

Ambalal Sarabhai Enterprises Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
35.29
+0.77 (+2.23%)
15:58 May 29
Quality
image/svg+xml

70/100
High Financial Strength

Valuation
image/svg+xml

57/100
Affordable Valuation

Technical

65/100
Technically Moderately Bullish

Strength

12

Weakness

1

Opportunity

0

Threats

0

11.24 %

ROE %

6.33 %

ROA %

2.32

EPS

20.66

BVPS

8.80 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
196.75 170.28 173.57 196.19 202.27
Operating Expenses +
171.85 161.71 167.25 188.11 190.51
Raw Material
114.07 105.24 98.62 121.48 119.34
Increase Decrease in Cost
0.64 -2.38 2.4 -5.98 -0.2
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
25.3 25.33 27.7 30.7 32.55
Miscellaneous Expenses
234.52 217.84 205.35 245.83 239.08
Operating Profit
24.9 8.57 6.32 8.08 11.76
Other Income
42.02 12.49 10.37 11.38 15.17
Depreciation
2.32 2.76 3.57 4.01 3.94
Interest
1.7 2.44 3.76 4.26 4.09
Profit before tax and exceptio..
62.89 15.87 9.36 11.19 18.9
Exceptional Items
-15.11 0 0 -7 -0.82
PBT
47.77 15.87 9.36 4.19 18.08
Provision for Taxation
6.98 3.72 0.97 -0.1 0.7
Net Profit
40.8 12.14 8.39 4.29 17.38
NET Profit after MI
47.22 11.1 5.68 4.93 17.8
EPS
6.16 1.45 0.74 0.64 2.32
Operating Profit Margin (%)
12.66 5.03 3.64 4.12 5.81
Net Profit Margin (%)
24 6.52 3.27 2.51 8.8

Ambalal Sarabhai Enterprises Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 31.40 31.40 31.40 31.40 31.40 31.40
FII 0.00 0.30 0.30 0.40 0.40 0.00
Public 0.00 0.00 0.00 0.00 0.10 0.10
Others 68.60 68.30 68.30 68.20 68.10 68.50
Shareholder Shares Holding %
Research 360 logo
Download Our App On: